Eastgate Biotech Stock

Eastgate Biotech EBIT

The EBIT of Eastgate Biotech (ETBI) as of Aug 5, 2026 is -2.63 M USD. In the previous year, EBIT was -4.17 M USD — a change of -36.87% (higher).

EBIT

-2.63 MUSD

YoY

-36.87%

Last updated:

In 2026, Eastgate Biotech's EBIT was -2.63 M USD, a -36.87% increase from the -4.17 M USD EBIT recorded in the previous year.

The Eastgate Biotech EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (undefined USD)
Date
EBIT (undefined USD)
Jan 1, 2009
0.00 base
Jan 1, 2010
0.00 base
Jan 1, 2011
0.00 base
Jan 1, 2012
0.00 base
Jan 1, 2013
0.00 base
Jan 1, 2014
0.00 base
Jan 1, 2015
0.00 base
Jan 1, 2016
0.00 base
YEAREBIT (undefined USD)
2016 -
2015 -
2014 -
2013 -
2012 -
2011 -
2010 -
2009 -
2008 -
2007 -
2006 -
2005 -
Access this data via the Eulerpool API

Eastgate Biotech Revenue

Eastgate Biotech Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2009
0.00 USD
-20,000.00 USD
-20,000.00 USD
Jan 1, 2010
0.00 USD
-20,000.00 USD
-20,000.00 USD
Jan 1, 2011
0.00 USD
-23,900.00 USD
-29,900.00 USD
Jan 1, 2012
0.00 USD
-605,797.00 USD
-622,820.00 USD
Jan 1, 2013
0.00 USD
-1.66 M USD
-1.72 M USD
Jan 1, 2014
0.00 USD
-4.82 M USD
-4.91 M USD
Jan 1, 2015
132,025.00 USD
-4.17 M USD
-4.28 M USD
Jan 1, 2016
0.00 USD
-2.63 M USD
-2.98 M USD

Eastgate Biotech Margins

Eastgate Biotech stock margins

The Eastgate Biotech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Eastgate Biotech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Eastgate Biotech.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2009
85.46 %
- %
- %
Jan 1, 2010
85.46 %
- %
- %
Jan 1, 2011
85.46 %
- %
- %
Jan 1, 2012
85.46 %
- %
- %
Jan 1, 2013
85.46 %
- %
- %
Jan 1, 2014
85.46 %
- %
- %
Jan 1, 2015
85.46 %
-3,159.54 %
-3,242.80 %
Jan 1, 2016
85.46 %
- %
- %

Eastgate Biotech Stock analysis

What does Eastgate Biotech do? Eastgate Biotech Corp is a biotechnology company specialized in the development and marketing of natural nutritional products and medicines. The company was founded in Canada in 1999 and is headquartered in Toronto. Eastgate Biotech Corp is listed on the Canadian Securities Exchange and is one of the leading companies in the field of biological medicine. The company's business model is based on the research and development of natural supplements and medicines made from plant and animal ingredients. Eastgate Biotech Corp aims to develop products that improve the well-being of humans and animals and can be manufactured in a natural way. The company relies on the use of innovative technologies and advanced research methods. Eastgate Biotech Corp operates in various sectors including medicine, animal health, and agricultural production. In the field of medicine, the company specializes in the development of medicines for the treatment of various diseases. It uses plant and animal ingredients to create natural remedies. In the animal health sector, Eastgate Biotech Corp offers products specifically designed for the health and well-being of livestock. The company is also involved in agricultural production, offering products that contribute to increasing crop yields. The range of products offered by Eastgate Biotech Corp includes a wide variety of nutritional supplements and medicines. The company offers products that support a healthy diet and help meet the needs for vitamins and minerals. Additionally, Eastgate Biotech Corp offers products that help strengthen the immune system, lower cholesterol levels, or regulate blood pressure. Products for weight control and metabolism support are also available. Some of the most well-known products from Eastgate Biotech Corp include the nutritional supplements "Celergen" and "Deltaweight". "Celergen" is a highly effective preparation that can help increase physical performance, smooth the skin, and improve mental fitness. "Deltaweight" is a nutritional supplement specifically developed for those looking to lose weight or maintain their weight. The product contains a unique blend of natural ingredients that can stimulate metabolism and reduce appetite. Eastgate Biotech Corp has undergone impressive development in recent years and is now one of the leading companies in the field of biological medicine. The company has an experienced team of scientists and experts who support the development of new products. Eastgate Biotech Corp relies on the use of advanced research methods and innovative technologies to manufacture new preparations that can improve the well-being of humans and animals in a natural way. Eastgate Biotech is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Eastgate Biotech's EBIT

Eastgate Biotech's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Eastgate Biotech's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Eastgate Biotech's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Eastgate Biotech’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Eastgate Biotech stock

EBIT of Eastgate Biotech is -2.63 M USD in 2026.

EBIT of Eastgate Biotech changed from -4.17 M USD to -2.63 M USD, representing a -36.87% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Eastgate Biotech since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Eastgate Biotech historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Eastgate Biotech

All Key Metrics — Eastgate Biotech